Ariad Pharmaceuticals Inc fka ARIA

[flexinvester]

The report reads as follows:

As of July 15th, there was short interest totalling 30,411,404 shares, a decrease of 7.6% from the June 30th total of 32,923,572 shares. Based on an average daily trading volume, of 2,901,567 shares, the short-interest ratio is presently 10.5 days. Approximately 16.5% of the company’s shares are sold short.

This in a CALCULATION based on volume and days to cover as of July 15. Since then how would they know REALLY what the mix was between New Longs Buying, Exising Longs selling, New Shorts and Shorts Covering?

With that, I DO NOT believe that anyone legally can know with certainty (NOT a calculation with a lot of assumptions) the short interest between reports otherwise there would be daily information available with an analysis that would be tantamount to inside information. I WISH.

I will await the actual report from NASDAQ on August 9 before coming to a conclusion, thank you.